As part of its continued commitment to regional growth,
DEVARTLab is proud to reinforce its longstanding partnership with Cigalah Gulf
Medical, one of the leading and most trusted medical distribution companies in
the Kingdom of Saudi Arabia.
This strategic collaboration has already enabled the
successful introduction of Hyalolite—a flagship nutricosmetic product—into the
Saudi market, where it has gained remarkable traction among dermatologists,
pharmacists, and end users.
Looking ahead, DEVARTLab is preparing to expand this
partnership by rolling out additional key products such as Roofa and Exotropin,
reflecting the shared vision of both companies to deliver high-quality,
specialized medical solutions tailored to the evolving needs of healthcare
providers and patients in the Kingdom.
DEVARTLab deeply values its partnership with Cigalah Gulf
Medical and appreciates their pivotal role as a strategic distribution partner
who brings extensive market knowledge, operational excellence, and a genuine
commitment to delivering healthcare innovation.
Cigalah Gulf Medical is not just a leading distributor in
the Saudi market — it is a true success partner with a forward-thinking vision
and exceptional professionalism in delivering comprehensive healthcare
solutions.
This partnership stands as a testament to DEVARTLab’s
strategy of building a global distribution network rooted in reliability,
scientific excellence, and shared values.